Rocket Pharmaceuticals (RCKT) EPS (2015 - 2026)
Rocket Pharmaceuticals (RCKT) EPS from Jun 30, 2015 to Mar 31, 2026. The TTM Rocket Pharmaceuticals (RCKT) EPS is -$1.93. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Rocket Pharmaceuticals (RCKT) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -26.77% |
| 3 Years TTM | -15.87% |
| 5 Years TTM | -5.96% |
| 10 Years TTM | -4.16% |
| All Time TTM | -4.83% |
Annual EPS change of Rocket Pharmaceuticals (RCKT)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.44 | -78.83% |
| 2025 | -$2.06 | -15.26% |
| 2024 | -$2.43 | -10.65% |
| 2023 | -$2.72 | -2.99% |
| 2022 | -$2.80 | +6.98% |
| 2021 | -$2.62 | +14.44% |
| 2020 | -$2.29 | +62.34% |
| 2019 | -$1.41 | -14.53% |
| 2018 | -$1.65 | +81.45% |
| 2017 | -$0.91 | +213.72% |
| 2016 | -$0.29 | -88.73% |
| 2015 | -$2.57 | N/A |
Comparison Rocket Pharmaceuticals (RCKT) five years EPS CAGR with competitors
Rocket Pharmaceuticals (RCKT) five years EPS CAGR is -5.96%.